Business Segments BriaCell Therapeutics Corp. Nasdaq
Stocks
BCTX
CA1079303071
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 3.930 USD | -0.76% |
|
+14.24% | -44.73% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
EBT: Breakdown by Business Segment
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Operating Income | -6.97M | -15.29M | -23.27M | -33.33M | -27.2M | |||||
Net Income | -428K | -26.84M | -20.3M | -4.79M | -26.31M | |||||
D&A | 15.26K | 15.27K | 15.27K | 83.9K | 107K | |||||
EBT | -428K | -26.84M | -20.3M | -4.79M | -26.31M | |||||
CAPEX | - | - | - | -457K | - | |||||
Interest Expense | -46.1K | -979 | - | - | -36.98K | |||||
Total Assets | 58.04M | 42.58M | 27.16M | 5.87M | 21.65M |
Geographical Revenue Distribution History
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|---|---|---|---|---|
Operating Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Total Assets | - | 230K | 215K | - | - |
- Stock Market
- Stocks
- BCT Stock
- BCTX Stock
- Financials BriaCell Therapeutics Corp.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
